drugset / Trial / NCT01020019

Combined Pharmacotherapy for Cannabis Dependency

NCT01020019 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to see if Lofexidine in combination with Marinol is superior to placebo in achieving abstinence, reducing cannabis use and reducing withdrawal in cannabis-dependent patients seeking treatment for their marijuana use.

Timeline

Start
2010-01
Primary completion
2014-09
Completion
2014-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Dronabinol Other / unclassified 20 mg —
Subject Lofexidine Small molecule 0.6 mg —

Indications